search this site
- home
- highlights
- sinclair at a glance
- growing our operations worldwide
- products:oral health
- products:dermatology
- chairman´s statement
- business review:operational
- business review:financial
- board of directors
- senior management
- directors´ report
- corporate governance report
- directors´ remuneration report
- independent auditors´ report
- consolidated income statement
- balance sheets
- statements of changes in shareholders´ equity
- cash flow statements
- notes to the financial statements
- corporate advisors
Balance Sheets
at 30 June 2008
Group |
Company |
||||||
2008
|
2007 |
2008
|
2007 |
||||
Note |
£'000
|
£'000 |
£'000
|
£'000 |
|||
| Non-current assets | |||||||
| Goodwill | 48,110 |
43,418 |
— |
— |
|||
| Intangible assets | 14,811 |
10,042 |
885 |
953 |
|||
| Investments | — |
— |
70,599 |
60,047 |
|||
| Porperty, plant and equipment | 1,827 |
1,976 |
— |
— |
|||
| Non-current tax assets | 708 |
1,512 |
— |
— |
|||
| Other non-current assets | 317 |
78 |
— |
— |
|||
65,773 |
57,026 |
71,484 |
61,000 |
||||
| Current assets | |||||||
| Inventories | 3,380 |
2,163 |
— |
— |
|||
| Trade and other receivables | 14,469 |
7,800 |
37 |
7,786 |
|||
| Current tax receivables | 1,580 |
22 |
— |
— |
|||
| Cash and cash equivalents | 1,052 |
2,791 |
— |
398 |
|||
20,481 |
12,776 |
37 |
8,184 |
||||
| Total assets | 86,254 |
69,802 |
71,521 |
69,184 |
|||
| Current liabilities | |||||||
| Financial liabilities - borrowings | (3,180) |
(567) |
(913) |
(101) |
|||
| Trade and other payables | (11,666) |
(7,134) |
(685) |
(482) |
|||
| Deffered income | (566) |
(423) |
— |
— |
|||
| Current tax liabilities | (86) |
(66) |
— |
— |
|||
(15,426) |
(8,190) |
(1,598) |
(583) |
||||
| Non-current liabilities | |||||||
| Financial liabilities - borrowings | (4,140) |
(709) |
(1,426) |
(384) |
|||
| Non-current tax liabilities | — |
(1,146) |
— |
— |
|||
| Deferred income | (357) |
(822) |
— |
— |
|||
| Other non-current liabilities | — |
(547) |
— |
(547) |
|||
(4,497) |
(3,224) |
(1,426) |
(931) |
||||
| Total liabilities | (19,923) |
(11,414) |
(3,024) |
(1,514) |
|||
| Net assets | 66,331 |
58,388 |
68,497 |
67,670 |
|||
| Equity | |||||||
| Share capital | 935 |
935 |
935 |
935 |
|||
| Share premium account | 21,472 |
21,472 |
21,472 |
21,472 |
|||
| Merger reserve | 50,474 |
50,474 |
55,574 |
55,574 |
|||
| Other reserves | 4,198 |
271 |
686 |
686 |
|||
| Retained deficit | (10,760) |
(14,775) |
(10,170) |
(10,997) |
|||
| Total Shareholders' equity | 66,319 |
58,377 |
68,497) |
67,670 |
|||
| Minority equity interests | 12 |
11 |
— |
— |
|||
| Total equity | 66,331 |
58,388 |
68,497 |
67,670 |
|||
The notes on pages 40 to 64 are an integral part of these consolidated finanical statements.
Approved by the Board of Directors on 31 October 2008.
DR MJ FLYNN
Chief Executive Officer